Drug Profile
FRM 6308
Alternative Names: EVP-6308; FRM-6308Latest Information Update: 25 Nov 2016
Price :
$50
*
At a glance
- Originator EnVivo Pharmaceuticals
- Developer FORUM Pharmaceuticals
- Class Antipsychotics; Mood stabilisers
- Mechanism of Action Phosphodiesterase 10A inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Schizophrenia
Most Recent Events
- 01 Jun 2016 Discontinued - Phase-I for Schizophrenia in USA (PO)
- 26 Apr 2016 Phase I development is ongoing in USA
- 30 Jun 2014 FORUM Pharmaceuticals completes a phase I trial in Healthy volunteers in USA (NCT02001389)